MeSH term
Frequency | Condition_Probility | Acute Disease | 2 | 0.0 |
Adult | 4 | 0.0 |
Comparative Study | 3 | 0.0 |
Humans | 49 | 0.0 |
Animals | 25 | 0.0 |
DNA (Cytosine-5-)-Methyltransferase/chemistry/genetics/*metabolism | 2 | 50.0 |
*DNA Methylation | 17 | 2.0 |
Mice | 23 | 0.0 |
NIH 3T3 Cells | 2 | 0.0 |
Protein Binding | 7 | 0.0 |
Protein Structure, Tertiary | 6 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 36 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 27 | 0.0 |
*CpG Islands | 2 | 2.0 |
DNA Methylation | 15 | 2.0 |
DNA, Neoplasm/metabolism | 2 | 1.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
*Genes, Tumor Suppressor | 2 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Protein p16/biosynthesis/genetics | 2 | 20.0 |
RNA, Neoplasm/biosynthesis | 2 | 1.0 |
Transcription, Genetic | 4 | 0.0 |
Tumor Cells, Cultured | 16 | 0.0 |
*Tumor Suppressor Proteins | 3 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Gene Silencing | 2 | 0.0 |
Kinetics | 7 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 10 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 3 | 0.0 |
3T3 Cells | 2 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
COS Cells | 5 | 0.0 |
Cell Line | 12 | 0.0 |
Cercopithecus aethiops | 3 | 0.0 |
DNA (Cytosine-5-)-Methyltransferase/genetics/*metabolism | 8 | 50.0 |
Female | 13 | 0.0 |
Gene Expression | 4 | 0.0 |
*Genomic Imprinting | 3 | 1.0 |
Male | 9 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Molecular Sequence Data | 11 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Aged | 5 | 0.0 |
Base Sequence | 7 | 0.0 |
CpG Islands | 6 | 2.0 |
Recombinant Proteins/genetics/metabolism | 3 | 0.0 |
Transfection | 5 | 0.0 |
*Gene Silencing | 3 | 1.0 |
Models, Genetic | 5 | 0.0 |
Blotting, Western | 2 | 0.0 |
S Phase | 2 | 0.0 |
DNA (Cytosine-5-)-Methyltransferase/*biosynthesis/genetics | 3 | 75.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
DNA/genetics/metabolism | 2 | 0.0 |
Glutathione Transferase/genetics/metabolism | 2 | 1.0 |
DNA (Cytosine-5-)-Methyltransferase/*genetics/metabolism | 3 | 50.0 |
DNA, Neoplasm/analysis | 2 | 0.0 |
RNA, Messenger/*metabolism | 2 | 0.0 |
Binding Sites | 3 | 0.0 |
Cell Line, Transformed | 3 | 0.0 |
DNA (Cytosine-5-)-Methyltransferase/genetics/*metabolism/physiology | 2 | 100.0 |
Histone Deacetylases/*metabolism | 2 | 1.0 |
*Transcription, Genetic | 5 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
DNA (Cytosine-5-)-Methyltransferase/*genetics | 8 | 28.0 |
Middle Aged | 4 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Models, Molecular | 2 | 0.0 |
*Gene Expression Regulation, Enzymologic | 3 | 0.0 |
Plasmids | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
DNA (Cytosine-5-)-Methyltransferase/genetics | 4 | 40.0 |
Tissue Distribution | 3 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Spodoptera/cytology | 2 | 4.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Blastocyst/*metabolism | 2 | 8.0 |
Pregnancy | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Hela Cells | 3 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
